These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8871060)
1. The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils. Tool AT; Mul FP; Knol EF; Verhoeven AJ; Roos D Eur Respir J Suppl; 1996 Aug; 22():141s-145s. PubMed ID: 8871060 [TBL] [Abstract][Full Text] [Related]
2. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of salbutamol and salmeterol on human eosinophil responses. Ezeamuzie CI; al-Hage M J Pharmacol Exp Ther; 1998 Jan; 284(1):25-31. PubMed ID: 9435156 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate. Tool AT; Verhoeven AJ Arzneimittelforschung; 1995 Oct; 45(10):1110-4. PubMed ID: 8595070 [TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro. Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583 [TBL] [Abstract][Full Text] [Related]
6. Blockade of LTC4 synthesis caused by additive inhibition of gIV-PLA2 phosphorylation: Effect of salmeterol and PDE4 inhibition in human eosinophils. Meliton AY; Muñoz NM; Liu J; Lambertino AT; Boetticher E; Myo S; Myou S; Zhu X; Johnson M; Leff AR J Allergy Clin Immunol; 2003 Aug; 112(2):404-10. PubMed ID: 12897749 [TBL] [Abstract][Full Text] [Related]
7. Evidence that the eosinophil is a cellular target for the inhibitory action of salmeterol on eosinophil recruitment in vivo. Teixeira MM; Hellewell PG Eur J Pharmacol; 1997 Apr; 323(2-3):255-60. PubMed ID: 9128847 [TBL] [Abstract][Full Text] [Related]
9. [Effects of anti-asthmatic drugs on human eosinophil chemotaxis]. Numao T; Fukuda T; Akutsu I; Makino S Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):65-71. PubMed ID: 1645817 [TBL] [Abstract][Full Text] [Related]
10. Modulation of eosinophil activation in vitro by a nicotinic receptor agonist. Blanchet MR; Langlois A; Israël-Assayag E; Beaulieu MJ; Ferland C; Laviolette M; Cormier Y J Leukoc Biol; 2007 May; 81(5):1245-51. PubMed ID: 17289799 [TBL] [Abstract][Full Text] [Related]
11. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent. Ezeamuzie CI; al-Hage M; Nwankwoala RN Int J Immunopharmacol; 1997 Aug; 19(8):421-30. PubMed ID: 9568547 [TBL] [Abstract][Full Text] [Related]
12. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator. Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372 [TBL] [Abstract][Full Text] [Related]
13. Taurine chloramine inhibits functional responses of human eosinophils in vitro. Martinez-Losa M; Cortijo J; Piqueras L; Sanz MJ; Morcillo EJ Clin Exp Allergy; 2009 Apr; 39(4):537-46. PubMed ID: 19222497 [TBL] [Abstract][Full Text] [Related]
15. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro. Nabe T; Yamamura H; Kohno S Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704 [TBL] [Abstract][Full Text] [Related]
16. Cooperation between Fc gamma receptor II and complement receptor type 3 during activation of platelet-activating factor release by cytokine-primed human eosinophils. van der Bruggen T; Kok PT; Raaijmakers JA; Lammers JW; Koenderman L J Immunol; 1994 Sep; 153(6):2729-35. PubMed ID: 8077677 [TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. Wardlaw AJ; Moqbel R; Cromwell O; Kay AB J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451 [TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils. Fukuda T; Numao T; Akutsu I; Makino S J Lipid Mediat; 1992; 5(2):145-9. PubMed ID: 1525356 [TBL] [Abstract][Full Text] [Related]
19. The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Faccioli LH; Nourshargh S; Moqbel R; Williams FM; Sehmi R; Kay AB; Williams TJ Immunology; 1991 Jun; 73(2):222-7. PubMed ID: 1649126 [TBL] [Abstract][Full Text] [Related]
20. Effects of intracellular cyclic AMP modulators on human eosinophil survival, degranulation and CD11b expression. Momose T; Okubo Y; Horie S; Suzuki J; Isobe M; Sekiguchi M Int Arch Allergy Immunol; 1998 Oct; 117(2):138-45. PubMed ID: 9784658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]